Cisatracurium Besylate Structural Formula (Cisatracurium Besylate Injection Usp Pf 1)
Cisatracurium Besylate Injection
Product Images NDC 0143-9396
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0143-9396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Cisatracurium Besylate Injection Usp Pf 2)
This appears to be a chart or graph representing data for a certain period of time. It shows a percentage increase of 60% over a 4-hour period and has the label "MAP" at the top. The other two lines on the graph appear to have a similar increase of around 60%. However, without more context, it is difficult to determine the exact meaning and interpretation of the data presented.*
Figure 2 (Cisatracurium Besylate Injection Usp Pf 3)
The given text is not clear and contains just a few mathematical symbols without any context and explanation. Hence, a useful description cannot be generated. It is not-available.*
Cisatracurium 5 mL Label (Cisatracurium Besylate Injection Usp Pf 4)
This is a warning about the prescription drug Cisatracurium Besylate, which is a paralyzing agent. It may cause respiratory arrest, and facilities for immediate intervention should be available. This injection is torpytogenic and should only be administered intravenously. The usual dosage should be noted by the package insert. The drug comes in a single-dose vial, diluted by Berkley Heights. Lot and expiration information is also provided.*
Cisatracurium 5ml Sdv Pf Carton (Cisatracurium Besylate Injection Usp Pf 5)
Cisatracurium Besylate Injection USP is a paralyzing agent that causes respiratory distress. It contains benzmasulons 6 and is recommended for immediate use in case of facial spasms. This medication is available in single doses, and it is important to use it within 21 days after refrigeration. The injection is for intravenous use only, and the packaging contains dosage information and prescribing information. Store at 2° to 8°C and discard any unused portion. The manufacturer of this medication is Hikma, and the product is produced in Portugal.*
Representative Serialization Image (Cisatracurium Besylate Injection Usp Pf 6)
This text provides product identification and tracking information including the GTIN (Global Trade Identification Number) code, serial number, expiration date, and lot number. It is commonly used in industries where traceability and quality control are critical, such as pharmaceuticals or food production.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
